Australia's largest stock trading and investment forum Australia's #1 stock forum

SP1

0.00%

$1.07 southern cross payments ltd

ASX Incompetent?, page-31

First 31 Last

Share
Profile

Follow
hopper

2,068 Posts.

54

26/11/19

13:44

Post #: 41637586
Share

Originally posted by itzgr82balive ↑

Actually, this is a smart move by ISX if the following assumptions are true:
1. ISX recognises that the bulk of the recent questions are related to the June Qtr revenue figures,
2. ISX's move would indicate to the market that ISX is confident that the ASX would not find corruption that would warrant the de-listing of ISX.
3. ISX knows that the likely disciplinary action by ASX for ISX would be, if no corruption was found, the ASX would require the ISX shareholders to give back the performance shares to the company, ISX
4. Therefore, ISX would have taken off the table the prime reason there would be speculation and market volatility around ASX questions and the market could then effectively and reliably trade.

If I was speculating on why the ASX said no, I would state that the ASX:
a. has remaining questions that are not associated with the performance shares, or
b. believes it has evidence of corruption in the declaration of that revenue that may warrant the de-listing of ISX.

Both are reasonable assumption for which I cannot find documented evidence, so we might as well just wait and see.

Expand

If ASX only issue with ISX is on the performance shares delisting ISX a viable public listed coy would be overkill. I m guessing if there is a need to cancel the performance shares then a new prospectus may have to be launched. IMO.

ISX Price at posting: $1.07 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel